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 Pathogenic bacteria have become increasingly resistant to antibiotics and alternative 
treatments for infections are being developed. One such treatment, phage therapy, involves 
using bacteriophages to destroy the bacteria; however, they must first be isolated. Raw 
sewage is a commonly evaluated source due to the incredibly high quantity and diversity of 
bacteria found within it. This research aims to assess the quantity of phages against chosen 
pathogens in the sewage from the San Angelo Water Reclamation Facility. Escherichia coli, 
Salmonella typhimurium, Serratia marcescens, Staphylococcus aureus, Staphylococcus 
epidermidis, and Streptococcus mutans were evaluated because of the important roles they 
play in healthcare and the food industry. Quantities were assessed by forming lawns of 
bacteria and filtered sewage and counting the number of clearings, called plaques, that form. 
This method showed that phage could be isolated for four of the bacteria with two being 
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INTRODUCTION 
Antibacterial resistance is currently the greatest problem in infectious diseases that 
the world is facing per the World Health Organization’s report in 2015 (1). This is largely 
due to the increase of “superbugs” or strains of bacteria that carry multiple antibiotic resistant 
genes. The most recognizable to the public is likely Methicillin-resistant Staphylococcus 
aureus (MRSA) due to its heavy media coverage. These strains are much more difficult to 
treat as the drugs historically used are no longer effective in eliminating them. Since these 
resistant strains continue to evolve at an increasing rate, the need for novel drugs to be 
developed by pharmaceutical companies has reached new levels (2). Unfortunately, despite 
the rising demand, pharmaceutical companies are hesitant to push large amounts of capital 
into the research and development of antibiotics as they are no longer as profitable. The 
heightened aversion to venturing too deeply into the antibiotic market stems from a multitude 
of factors including the surge of regulations, testing requirements, and the difficulty of 
creating a new and effective antibiotic, all of which have lengthened the development process 
and made the endeavor much more expensive (2). Justifying these costs is difficult for 
companies when their drug, if they succeeded in creating one that meets all standards and 
trials, inevitably falls victim to the same plight as the other antibiotics on the market and is 
rendered useless because the target strain develops a resistance to it. For these reasons and 
more, researchers have looked to different treatment methods to fight pathogenic bacteria. 
One possible solution to this ever-growing problem could be found in bacteriophages 
which were originally discovered independently by Frederick Twort and Felix d’Herelle 
2 
(3,4). A bacteriophage is a virus that hijacks a bacterium’s molecular machinery and forces it 
to serve as a factory producing mass quantities of the virus. As the phage finishes replicating, 
enzymes are released that break down the cell wall leading to lysis thus spilling the viral 
progeny into the environment. Not only does this kill an individual bacterium immediately, it 
also increases the likelihood of infecting other bacteria due to this increase in the number of 
phages in the environment. Unlike lytic viruses, temperate viruses can go through a lysogenic 
cycle in which the viral DNA will insert itself in the host’s DNA and will be passed on to the 
daughter during cell division, until the conditions are ideal, at which point the viral DNA will 
excise itself and enter the lytic cycle. During either life cycle, the virus could potentially 
transfer DNA from one bacterial host to another in a process called transduction. Although it 
is not a novel technique, phage therapy could be a promising complementary or alternative 
strategy for combating antibiotic resistant pathogens. Phage therapy involves using lytic 
phages to infect and ultimately kill the infectious agent.  
Experiments using phage therapy have been performed for nearly a century beginning 
with Felix d’Herelle who was a French-Canadian microbiologist. d’Herelle used the newly 
discovered phages to treat patients that were suffering from bacillary dysentery, or now 
commonly called shigellosis, which is known to be caused by a genus of bacteria called 
Shigella (4). Although d’Herelle and others created viable treatments, the life cycle of the 
phages was not fully understood.  Early experiments were consequently abandoned by much 
of the world, except Russia, Poland, and the country Georgia. This was especially so when 
the first antibiotic was discovered and widely used during WWII (5). However, interest in the 
possibilities offered by phage therapy has resurged in recent years as concern for superbugs 
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increases. The increased worldwide interest has led to countries with a long history of using 
phage therapies, such as Georgia, to share their findings. This information, along with the 
advancements in virology as a whole, has stimulated researchers to re-evaluate the various 
advantages and disadvantages of using phage therapy over chemical antibiotics. In this 
regard, phage therapy has some major advantages.  
The first advantage is that, unlike some antibiotics, a bacterium is unable to regain 
viability if it is successfully infected by an obligately lytic phage (6). This decreases the 
chance that the bacterium will incur or pass on any form of phage-resistant traits thus 
increasing the potential time that the phage can be used as treatment. Another advantage is 
that, if a phage with a limited specificity is chosen, the normal flora of the patient would not 
be disturbed (6). This is not true for many broad range antibiotics which can lead to a 
secondary infection in the GI tract by an antibiotic resistant bacterium like Clostridium 
difficile. A final advantage is its usefulness in penetrating the tough biofilm that is produced 
by some bacteria (7). A biofilm is a community of microbes that has embedded itself in a 
polysaccharide matrix bound to an inanimate surface. Once in a biofilm, the community is, as 
a whole, much more resistant to attacks by the immune system, phagocytosis, and antibiotics. 
Not only can a biofilm be tough to eradicate under normal circumstances but, if it forms on 
an inorganic implant in the body, it can go completely undetected by the immune system 
until it progresses too far to be treated by conventional means. In this situation, the implant is 
usually removed so that the biofilm does not slough off some of its layers and spread to other 
surfaces throughout the body. Phage therapy has the ability to break through the layers of the 
biofilm, in part due to the fast proliferation of phages and the close proximity of the bacteria 
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(7). However, it has been observed that this can lead to the development of phage resistance 
in the community at a higher rate. To combat this, it has been suggested that a combination 
of a phage cocktail, antibiotics, and antiseptics be used (8).  
Despite these advantages, there are some concerns that must be considered before 
implementing phage therapy as a standard treatment in hospitals. Before a phage is used it is 
important to ensure that it is obligately lytic because if it can exhibit a lysogenic phase the 
chance of promoting the development of phage-resistance increases. The phages also must 
have a high virulence to ensure the death of the bacterium and a low rate of transduction to 
limit the dissemination of traits that could decrease the bacterium’s sensitivity to phage 
therapy. Apart from the phage’s behavior and virulence, its morphological characteristics 
should be observed, and its full genetic code should be sequenced to check for any red flags 
(6). While phages have demonstrated immense potential as a treatment for human infections, 
they may also possess widespread benefits for the environment and food industry. 
 The coral reefs around the world have been greatly reduced by destructive fishing, 
pollution, and rising greenhouses gases. This habitat is home to a large amount of 
biodiversity with many species being unique to the areas.  Along with this reduction comes 
the weakening of the population thus opening them up for large-scale disease outbreaks. One 
such disease is caused by Vibrio coralliilyticus which typically infects hard coral but can also 
spread to soft coral, oyster larvae, and bivalve larvae (9). Treating this disease can be 
difficult because strains have already begun to show multiple antibiotic resistance with some 
strains showing resistance to commonly used drugs like ampicillin, amoxicillin, 
erythromycin, and sulphamethoxasole (10). When added at an early stage phage therapy has 
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been shown to help the coral defend against the pathogen and reduce the chance of spreading 
the disease to others (9). As this area of research continues, more uses for these phages in the 
environment could be discovered. 
There are numerous ways in which phages can be used in the food industry for 
human, animal, and plant protection without weakening the antibiotics currently being used. 
In 2011 the global fruit and vegetable industry grew in value to a staggering $1.5 trillion 
despite the pressure caused by plant disease and adverse weather in some areas (11). 
Although the industry has seen growth, it is still hampered by the cost of the war against 
phytopathogens. When only considering the top eight US cash crops, the cost of treating 
pests and infections pre-harvest was estimated to be $300 billion (12). Historically the main 
treatments for these diseases have included chemical antibiotics, copper-based bactericides, 
and pesticides, but increased resistance and their environmental impact have led to countries 
banning some of the practices (11). Along with crop production, the spread of foodborne 
diseases through consumption is another strain on the US economy with these illnesses 
costing the US an estimated $152 billion dollars per year (13). Because these industries are 
so economically important, the search for alternative treatments for crop diseases and ways to 
kill bacteria on products has already led to multiple FDA and USDA approved phage 
preparations hitting the market for commercial use.  
ListShield™ and PhageGuard Listex™ are two examples of phage preparations that 
target the pathogen Listeria monocytogenes which can be found in raw or packaged food 
products such as fresh catfish, ice cream, soft cheeses, and some fruit and vegetables (14,15). 
This is an important pathogen because L. monocytogenes infects about 1,600 people each 
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year with about 260 deaths (16). Listeriosis is usually caused by consuming contaminated 
food. The symptoms include: fever, diarrhea, confusion, and convulsions in most adults but 
can lead to miscarriage, or premature delivery in pregnant women (16). Listeriosis is 
typically treated with ampicillin or other B-lactams. However, if a patient is allergic to these, 
co-trimoxazole (a combination of trimethoprim and sulfamethoxazole) is the second-line 
therapy (17). Of the 202 strains of Listeria monocytogenes isolated and tested from food and 
the environment collected in France between 1996 to 2006, only 4 strains showed resistance. 
One of the strains was resistant to trimethoprim (17). If co-trimoxazole is used irresponsibly 
the gene that codes for its resistance could become more widespread. Using PhageGuard 
Listex™ on at-risk products could lengthen the lifespan of co-trimoxazole by limiting 
infections and thus lower the chance that incidental resistance will develop.  
Bacteria pathogenic to plants and other crops could also be potentially treated with 
phage therapy. Phytopathogens can have a devastating impact on both local food stores and 
the global economy. However, due to the immense variation that is found in the bacterial 
strains that can infect one plant, it is difficult to isolate the appropriate phages necessary to 
effectively protect the plants (18). To fully treat the diseases a combination of phages is 
typically required. The other issues impeding the use of phages on a large scale for crop 
treatment is their low viability in the phyllosphere and their ability to access the bacteria. The 
phages have been shown to be susceptible to many environmental hazards including high 
temperature, pH changes, and rain (18). Furthermore, the most deleterious environmental 
hazard has been shown to be ultraviolet radiation originating from sunlight which can be 
disastrous for phage treatment. There have been multiple attempts to treat different strains of 
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Xanthomonas which can infect citrus, walnuts, tomatoes, and peach trees (11). From these 
experiments it has been found that suspending the phages in skim milk along with proper 
timing of their application can improve persistence (18). 
While phage cocktails have been approved in the Western world for eradicating 
bacteria in food products, it has not yet been deemed safe enough for the treatment of 
diseases in humans. Understandably, this is not a simple process and it will take some time to 
conquer the hurdles that lie ahead before the FDA or other government entities approves it. 
To be approved, the FDA must be confident that the known and potential risks of a drug are 
outweighed by the benefits it provides to a patient (19). To make this decision the FDA takes 
a few things into consideration. First, they will use the currently available treatment options 
as a point of comparison for the potential new drug’s risks. Next, the group that is proposing 
the use of the drug will need to submit at least two clinic trials that are well-designed and 
show that the treatment is effective and is not going to cause more harm than good to the 
patients. Finally, appropriate drug labels will need to be created that clearly outline how the 
drug will impact the consumer. Typically, the review process takes approximately 10 months 
after all pertinent information is provided (19).  
While this may seem straightforward, these types of trials usually involve very stable 
chemical drug products and the regulations surrounding drug approval reflect this standard 
(20). This poses an issue for phage therapy because the phage cocktails that are used do 
undergo some changes to better adapt to the host bacteria that the treatment is targeting. It 
has been suggested that a special amendment for phage therapy should be made that also 
implements a strict monitoring system that will assess the development of resistance to 
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phages (20). Currently the only place that patients seeking phage therapy can go to receive 
treatment is the Eliava Phage Therapy Center in Tbilisi, Georgia (21). This facility advertises 
that they can successfully treat a variety of ailments such as skin, bone, eye, and urinary tract 
infections along with gastrointestinal diseases like irritable bowel disorder and bacterial 
gastroenteritis. Excluding travel costs, they state that, if the patient stays the recommended, 
7-14 days, that the treatment will cost a total of €3900 or about 4,700 USD as of May 2018 
(21). Despite already being regularly used in Georgia there have been very few published 
clinical studies that are well-conducted, randomized, double blind, and placebo controlled 
(20, 22). This issue is of the utmost importance because drug-approving bodies must be 
certain of a treatment’s impact on the human body and without sufficient data on how phage 
cocktails work in vivo they will not be approved any time soon in the US (22).  
In order to use bacteriophages, they must first be located. Many sources are used 
today including sewage, soil, and bacterial colonies. Raw sewage is a commonly evaluated 
source due to the incredibly high quantity and diversity of bacteria found within it that could 
be used to find a host for the bacteriophages (6). Cai et al. have shown that bacteria living in 
the sewage found at the beginning of wastewater treatment plants will reflect the human 
microbiome. This study also showed that the human gut microbiome was the greatest 
influence on the bacterial profile of this influent sewage. This study was unable to determine 
the bacteria to the species level. However, it showed that Proteobacteria, which includes 
Escherichia and Salmonella, made up 34% of the bacteria found (23). Therefore, using 
sewage as a source for the phages is a viable alternative to attempting to sample a significant 
portion of the San Angelo population as the bacteria in the wastewater represent those of the 
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entire population. It is important that sewage facilities around the world are examined 
because, much like soil, a virus found in one region could have key characteristics that make 
it useful for therapy that may not be found in a phage similar to one found elsewhere due to 
their high diversity (24). The San Angelo Water Reclamation Facility was chosen for this 
research because its potential as a source for bacteriophages had not been previously 
evaluated. 
Escherichia coli, an intestinal colonizer, was used as the baseline for the project 
because data collected previously indicated phages could be reliably found in high numbers 
in this water source. The other bacteria selected for this study are the intestinal colonizers 
Salmonella typhimurium and Serratia marcescens, skin colonizers Staphylococcus aureus 
and Staphylococcus epidermidis, and an oral colonizer Streptococcus mutans. These bacteria 
were chosen because they each play an important role in healthcare and in agricultural 
systems around the world.   
Escherichia coli is a gram-negative, facultative anaerobic rod and is a member of the 
Enterobacteriaceae family. Many E. coli strains are part of the normal flora of the 
gastrointestinal tract in humans and are usually nonpathogenic. However, some strains can 
cause infections accompanied by symptoms ranging from asymptomatic to life threatening 
with the site of infection often being strain specific. A well-documented and dangerous strain 
is the Shiga toxin producing Escherichia coli O157: H7 (25). This strain is a foodborne 
pathogen that causes dysentery, or bloody diarrhea, and is often associated with consuming 
undercooked beef, cheeses, yogurt, or raw unwashed vegetables. This strain is infamous for 
causing outbreaks on both small and large scales and there are, on average, 73,000 cases per 
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year in the United States (26). The treatment of these infections is typically handled by broad 
spectrum antibiotics that wreak havoc on the normal flora of the GI tract. For these reasons, 
E. coli is an important candidate for phage therapy. 
Salmonella typhimurium is a gram-negative, facultative anaerobic rod that does not 
form capsules or spores. Per year, there are approximately one million cases of foodborne 
illnesses in the United States caused by Salmonella strains including S. typhimurium, S. 
enteritidis, and S. typhi (27). The most common symptoms of salmonellosis include diarrhea, 
fever, and abdominal cramps. The infection typically lasts about a week without treatment, 
but death can occur if the patient is elderly, young, immunocompromised or the diarrhea is 
severe enough (27). Infections usually occur when food, contaminated with the pathogen, is 
undercooked, and then ingested or handled raw. There are two prominent methods being 
tested to reduce Salmonella on foods such as poultry, eggs, pork, and produce. One method 
involves directly spraying phage preparations on the food item or fully submerging the item 
into the solution. This method has been shown to significantly reduce phage concentration of 
the three major Salmonella strains on multiple food matrices (28). The other major method 
being tested treats the animal instead of the product. The phage preparations were orally 
administered every two or three days to chickens directly infected with S. typhimurium. This 
experiment resulted in a significant reduction of salmonella in the chicken cecum if doses 
were given frequently (29). One issue they encountered was, after causing a reduction in 
bacteria, the number of bacteria began to rise once again. It was hypothesized that there were 
not enough phages circulating to encounter the remaining bacteria to completely eliminate 
the infection after already killing most of the population. In this case, it may be beneficial to 
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use a combination of phages and antibiotics to fully wipe out the bacteria. Both of these 
techniques will need many more trials to improve their effectiveness and reliability before 
they are brought to the market. However, if either of these methods is put to use, the number 
of infections and deaths caused by salmonellosis could be reduced.  
Serratia marcescens is a gram negative, saprophytic rod, of the Enterobacteriaceae 
family. It is known for the bright red pigment, prodigiosin, it produces which has led to its 
use as a biological marker for studies examining the spread of bacteria. The infections are 
usually nosocomial (hospital acquired) and can cause urinary tract infections, endocarditis, 
septicemia and more depending on the site of infection (30, 31). S. marcescens is highly drug 
resistant with some strains being resistant to both extended-spectrum beta-lactamase and 
metallo-beta-lactamase drugs. These multi-drug resistant strains have been responsible for 
many hospital outbreaks when they contaminate soaps, handwashing stations, IV lines and 
more (31). Bacteriophages specific for this organism have been isolated from wastewater and 
soil and some of them, such as KSP90 and KSP100, have shown characteristics that would 
make them useful in phage therapy (32). 
Staphylococcus aureus is a staphyloxanthin producing, gram-positive coccus that 
forms clusters. It is part of the normal flora of humans and is found in the anterior nares of 
about 30% of people which is only one of the many places it can be found (33). The 
pathogenic strains can be extremely dangerous, especially in a hospital setting where 
immunocompromised patients can easily be infected by consuming contaminated foods or 
through poor aseptic technique. The severity of the infection is dependent on the location of 
the infection, but it is known to cause sepsis, pneumonia, endocarditis, osteomyelitis, and 
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more (33). The danger posed by this bacterium today stems from the difficulty in its 
eradication due, in part, to its resistance to a wide range of antibiotics. This is further 
complicated because many people have developed allergies to the antibiotics. There are 
Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, 
and other resistant strains found in hospitals and contaminated foods (33). Dairy products are 
one of the food types that can carry these pathogenic bacteria and they are not always fully 
eliminated by the pasteurization process. To combat this, it has been suggested that phage 
cocktails be applied to the product after the pasteurization step because the treatment 
hampers the effectiveness of the phages (34).  
Staphylococcus epidermidis is another gram-positive coccus that forms clusters and it 
is the most commonly isolated bacteria from human skin (35). Staph. epidermidis is an 
opportunistic pathogen that is primarily responsible for infections following the placement of 
an internal medical device. The bacteria are introduced to the medical device by either the 
patient’s own skin or from the skin of one of the healthcare providers and can lead to 
infections of the bloodstream. Because Staph. epidermidis can form biofilms, it can be very 
difficult to treat such infections with standard chemical antibiotics (35). Phages that produce 
proteins that degrade the extracellular material of Staph. epidermidis biofilms have been 
discovered (36). These phages could yield promising results if combined with other 
antimicrobials. One study recommended coating medical implants or catheters with phage 
cocktails prior to their insertion (37).  
Streptococcus mutans is a gram-positive, biofilm-forming coccus found in chains 
inside the mouth of humans. This bacterium is one of the primary bacteria in the onset of 
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dental caries which is one of the most common diseases in the world (34). These bacteria 
thrive in the mouth by breaking down sugars, such as sucrose, for use as a food source and as 
a building block for forming biofilms on the enamel of teeth. Once they form, these plaques 
produce high levels of acidic byproducts which wear down the enamel and produce cavities 
(38). Currently, these plaques can only be treated by scraping them off if it is early enough or 
drilling out the infected areas of the tooth and filling the hole if it has progressed too far. 
However, phages have been found in human saliva that, while they have a narrow host range, 
can reduce the growth and biofilm production of Strep. mutans (39). 
All of the bacteria selected for this study have been important in the development and 
understanding of the mechanics of phage therapy. However, to compete against these 
devastating pathogens, the ideal phages need to be found which, in turn, means that their 
presence should be recorded in as many locations as possible. Studying phage presence is 
imperative in understanding their interactions with their hosts in their environment, observing 
any shifts in the viral population, and for identifying areas that could be considered as 
potential sources for novel phages. This research aims to assess the quantity of phages 
against the chosen pathogens in San Angelo’s wastewater and whether related pathogens 
produce similar amounts. This will be answered by forming lawns with a mixture of bacteria 
and filtered sewage and counting the number of clearings, called plaques, that form after 24 
hours of incubation. The plaques that form indicate the presence of a bacteriophage lineage 
that has developed and destroyed the bacteria in an area.  
 It was hypothesized that the common enteric bacteria, E. coli and S. typhimurium, 
would produce similar numbers of plaques because of their frequent interaction with humans 
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and in turn the wastewater system. However, S. marcescens is not as common an intestinal 
pathogen outside of hospital settings so it was predicted that it would produce very few if not 
the fewest plaques. Next, it was predicted that similar numbers of bacteriophages would be 
found for the two staphylococci, Staph. aureus and Staph. epidermidis, because they are both 
commonly found on or in humans. Finally, it was thought that Strep. mutans would be 
readily introduced into the wastewater system through oral care and would thus make 
wastewater a valid source for finding bacteriophages against it.  
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MATERIALS AND METHODS 
Table number 1 displays each of the bacterial species used in this research along with 
their American Type Culture Collection (ATCC) type number and the site that they were 
originally isolated from. 
TABLE 1.     Strains used in the present study 
Species ATCC Number Isolation 
Escherichia coli 23848 N/A 
Salmonella typhimurium 13311 Food poisoning; feces, human, 1911 
Serratia marcescens 13880 Pond water 
Staphylococcus aureus 13565 Ham involved in food poisoning 
Staphylococcus epidermidis 49461 Clinical isolate 
Streptococcus mutans 25175 Carious dentine 
 
At the start of the project a pure culture of each of the six bacteria was made on 
Tryptic Soy Agar (TSA) (Acumedia Neogen Corp., Lansing, MI). Each of the bacteria came 
as a freeze-dried specimen and was revived using the guide produced by ATCC. The cultures 





Establishing a Baseline:  
Using the E. coli, a trial run of the experiment was done to gather preliminary results 
as a point of comparison for further tests. To do this, a flame-sterilized loop was touched to 
the pure culture of E. coli and then mixed to suspend the bacteria in 5.0 mL of Tryptic Soy 
Broth (TSB) (Acumedia Neogen Corp., Lansing, MI). The culture was then allowed to 
incubate for 24 hours at 35°C. The opacity of this overnight culture was used as a reference 
point for the required opacity for the other bacteria. Frozen wastewater was thawed at room 
temperature. The wastewater was poured into a sterile Corning® 250 mL vacuum 
filtration/storage bottle system with a 0.22 µm cellular acetate membrane and filtered with a 
vacuum pump until only solid particulates remained in the upper chamber. Using a 10.0 mL 
pipette, 5 mL of the filtered sewage was dispensed into the tube of E. coli and left 
undisturbed for 15 minutes. Then, a 1.0 mL pipette was used to add various aliquots of the 
mixture (0.1 mL, 0.2, mL, 0.3 mL, 0.4 mL, 0.5 mL, 0.6 mL, 0.7 mL, 0.8 mL, 0.9 mL, 1.0 
mL, 1.5 mL and 2.0 mL) to different vials of soft phage overlay agar (Nutrient broth 8g, 
NaCl 5g, Dextrose 1g, Bacteriological agar 8g, per 1000mL) that was kept liquefied at 45°C 
until it was ready to be used. The vial was then tapped three times to mix the contents and 
poured onto a plate of phage bottom agar (Nutrient broth 8g, NaCl 5g, Dextrose 1g, 
Bacteriological agar 15g, per 1000mL). The plate was then swiveled, until the entire plate 
was coated in liquid, and set aside until the top agar had solidified. These plates were 
incubated for 24 hours at 35°C. After incubation, the plates were evaluated and, because the 
higher volumes created too many plaques to count accurately, it was determined that, for 
future runs, 0.1 mL, 0.3 mL, 0.6 mL, and 0.9 mL would be used. 
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Bacteriophage Isolation and Enumeration: 
 Using the parameters determined in the previous section, phage isolation was done 
for each of the bacteria. Only one bacterium was tested at a time to ensure that each 
bacterium-phage mixture was given the same time for incubation. Streptococcus mutans did 
not produce consistent lawns on the phage bottom agar. Therefore, Brain Heart Infusion agar 
(BHI) (Acumedia Neogen Corp., Lansing, MI) was tested and produced much more reliable 
lawns when the bacterium was also grown in Brain Heart Infusion broth (Acumedia Neogen 
Corp., Lansing, MI). To quantify the plaques, each clearing was marked with a permanent 
marker and then counted and crossed out with a black pen. By counting in this manner, all 
the plaques were examined through both direct and indirect lighting before they were 
counted to ensure accuracy. 
Bacteriophage Enrichment: 
 Because Streptococcus mutans and Staphylococcus epidermidis did not produce any 
plaques through the standard isolation method the wastewater was analyzed with a different 
method. The purpose of a phage enrichment experiment is to evaluate whether there are any 
trace levels of a bacteriophage in the source. This method, provided by the Center for Phage 
Technology at Texas A&M University, does not give insight into how prevalent the phages 
are, just if there are any at all that can infect a certain bacterium (40). A culture was made for 
both Strep. mutans and Staph. epidermidis and allowed to incubate overnight at 35°C. This 
was done by inoculating a 250 mL Erlenmeyer flask containing 100 mL of media with the 
selected bacterium. TSB was used for Staph. epidermidis and BHI broth was used for Strep. 
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mutans as these broths yielded high densities for their respective bacterium. After 24 hours of 
incubation, 10 mL of wastewater that had been thawed and filtered in the same manner as 
described earlier, was combined with 40 mL of sterile media and the 100 mL of overnight 
culture in a 250 mL culture flask. This mixture was once again incubated for 24 hours at 
35°C to allow any bacteriophages against the bacteria in the solution enough time to infect 
and proliferate to an observable quantity.  
The mixture was then completely filtered through a 0.22 um cellulose-acetate vacuum 
filter as described earlier. To 4.0 mL of TSB or BHI broth, inoculated and incubated with 
Staph. epidermidis and Strep. mutans respectively, 5.0 mL of the filtrate was added and left 
undisturbed at room temperature for 15 minutes. Then as before, aliquots were mixed with 
the soft phage overlay and poured onto the phage bottom agar. Aliquots of 0.1 mL, 0.3 mL, 
0.6 mL, 0.9 mL, 1.5 mL, and 2.0 mL of mixture was used in this phase of the study. The 
Strep. mutans was poured onto plates of both phage bottom agar and BHI agar to account for 
the inconsistency of lawn formation on the phage bottom agar. Once the top agar gelled, the 
plates were placed in a 35°C incubator for 24 hours and afterward the plates were examined 
for the presence of plaques. This process was also repeated using fresh wastewater to ensure 
that freezing the water to preserve it did not damage the bacteriophages or reduce their 
viability.  
Data Analysis:  
Initially, the experiment was repeated ten times for each of the bacteria; however, 
there was poor lawn formation on some of the plates so true plaque amounts could not be 
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counted. This issue is reflected in the data as six runs were counted for S. typhimurium and 
nine for E. coli. The data were analyzed using the statistics software R. Because collected 
data were considered count data, they were put through a Poisson Regression analysis which 
compared the counts of each of the bacteria that produced plaques against those of the 
baseline E. coli to determine if they were statistically similar. However, because the data 
showed over dispersion a Quasi-Poisson Regression was used instead because it corrects for 
the issue. Next, the same process was done with Staph. aureus as the comparison point to test 
whether S. marcescens produced similar plaque counts to it at 0.9 mL. The results of these 
tests were used to draw conclusions as to the number of phages present in the wastewater in 
relation to one another.  
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RESULTS 
From the experiment, it was found that phages against Escherichia coli, Salmonella 
typhimurium, and Serratia marcescens could be isolated at all four volumes of mixture. This 
was not the case for Staphylococcus aureus which was only isolated at 0.9 mL of mixture 
consistently and twice at 0.6 mL with one of them being the fresh sewage. Furthermore, the 
final two bacteria, Staphylococcus epidermidis and Streptococcus mutans, had no phage 
isolates even when higher aliquots were used. To further confirm the lack of bacteriophages 
against these species, the phage enrichment experiment outlined earlier was done on them. 
Although higher levels of mixture were used, and the culture was given a longer incubation 
time with a high concentration of sewage filtrate, no plaques were visible on the lawns that 
formed. For Strep. mutans, a more evenly dispersed lawn was produced in the plates that 
used BHI agar in lieu of the standard phage bottom agar that was used for the other bacteria. 
Because these two bacteria did not produce any plaques, their data did not fit a Poisson 
distribution and were not used in the analysis as their numerous zeros would skew the 
analysis. The distribution of counts for plates that successfully produced plaques followed a 
Poisson distribution which, in turn, means that the mean and the variance of the model was 
equal, and a Poisson Regression could be used for analysis.  
S. typhimurium and E. coli plates produced similar plaque counts at all four quantities 


















Furthermore, this inference was able to be confirmed by putting S. typhimurium plate 
counts in a contrast matrix that modelled them against E. coli’s and it was determined that 
the counts were all significantly similar (Quasi-Poisson regression, at 0.1 mL p-value = 0.3, 
at 0.3 mL p-value = 0.1, at 0.6 mL p-value = 0.50, at 0.9 mL p-value = 0.09 mL). While the 
FIG 1 The number of plaques produced by Escherichia coli, Staphylococcus aureus, Serratia 
marcescens, and Salmonella typhimurium when 0.1 mL (A), 0.3 ml (B), 0.6 mL (C), and 0.9 mL 
(C) of sewage filtrate-pure culture mixture was added to the soft phage overlay. 
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S. marcescens plates did produce plaques, they produced considerably fewer than those 
plated with E. coli (Quasi-Poisson regression, at all amounts, p-value < 0.05). Furthermore, 
at 0.9 mL Staph. aureus plates also produced plaques which, much like S. marcescens, 
contained fewer than those of E. coli (Quasi-Poisson regression, p-value < 0.05).  
Because the S. marcescens and Staph. aureus plates produced so few plaques it was 
important to determine whether their counts were similar or different. Although the Staph. 
aureus count that was made when fresh wastewater was used is an outlier and is contained 
within the whisker of S. marcescens (FIG 2), their counts are not significantly similar (Quasi-
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FIG 2 The number of plaques produced by only Staphylococcus aureus and Serratia when 0.9 mL 
















 The original hypothesis was that the two bacteria tested in this study that can cause 
the greatest number of gastrointestinal infections, E. coli and S. typhimurium, would produce 
the highest number of plaques, followed by the staphylococci, Staph. aureus and Staph. 
epidermidis. The oral species, Streptococcus mutans was predicted to yield a minimal 
number and lastly Serratia marcescens was expected to produce the least. As per the results 
of the experiment it can be seen that this order was not correct. While it was true that E. coli 
and S. typhimurium yielded the most numerous plaques, the other bacteria did not yield the 
expected trend. Notably, little to no plaques were expected for S. marcescens but it yielded 
the third highest number of plaques. This was followed by Staph. aureus which was 
predicted to produce a similar number of plaques as Staph. epidermidis. However, Staph. 
epidermidis and Strep. mutans did not produce any plaques. Hence, the San Angelo Water 
Reclamation Facility appears to be a potential source for bacteriophages against E. coli, S. 
typhimurium, S. marcescens and Staph. aureus but not Staph. epidermidis and Strep. mutans. 
For bacteriophages to be found, it is necessary for the host bacteria to be present in the 
sample, in this case San Angelo sewage. The results seem to indicate that these species of 
bacteria are not equally likely to be found in sewage. It is important to search for 
explanations for these results to help shape future experiments. 
 As stated previously, E. coli and S. typhimurium plates displayed the highest number 
of plaques which indicates that there were more phages against them than any of the other 
bacteria. E. coli is part of the normal microflora of the human gut while S. typhimurium is 
not, which may be why the former seemed to have a slightly higher plaque amount on many 
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of the plates. It is expected that fecal waste from healthy humans would contain many more 
E. coli cells than S. typhimurium cells simply because the latter organism is less numerous in 
the guts of healthy people. However, it is also true that many animals, such as reptiles and 
amphibians carry Salmonella as normal microflora and therefore these organisms would be 
expected to be released into sewage from these sources (41,42). Despite this slight difference, 
according to the analysis, they did, in fact, produce similar plaque counts which suggests a 
similar number of phages in the wastewater. However, this may not indicate a direct 
correlation between the number of plaques and the levels of bacteria found in the sewage. 
This assumption can be drawn from studies that estimate the number of colony-forming units 
(cfu) per 100 mL to be ~106 for E. coli and ~102-104 for S. typhimurium (43,44). If these 
numbers are correct, then one would expect the numbers of bacteriophages specific for E. 
coli to be higher than the numbers specific for S. typhimurium. These findings are not 
consistent with and are not supported by previous research by Mandilara et al. which found a 
correlation between phage and host numbers in sewage (43). Their study also described a 
significant difference in the level of somatic coliphages, and F-specific coliphages in the raw 
sewage. Therefore, because in their study E. coli was used as the host for somatic coliphages 
and S. typhimurium was the host for F-specific coliphages, it is expected that they would get 
different numbers from those shown in the San Angelo wastewater. This difference in results 
could be due to several reasons. First, the number of bacteria in the local water source was 
not evaluated and because it is expected that fluctuations in the population of both species 
occurs, it is possible that the quantities of the two species were similar at the time of 
sampling (44). Secondly, our test may not be sensitive enough to discern a difference 
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between the two because of the imprecise method of creating the host culture broths.  Visual 
assessment was used to determine the number of bacteria in the broth based on the turbidity 
of the broth and the exact cfu of the overnight cultures was not known. Therefore, there may 
have been more host cells of the S. typhimurium than the E. coli, thus allowing for more 
phage interactions with the host bacteria.  
 S. marcescens is known to be able to survive relatively harsh conditions, even when 
outside of a biofilm, and is found in a wide variety of environments including freshwater, 
soil, sewage, and other non-potable water. Multiple phages have been previously isolated 
from wastewater and environmental water that show lytic activity to clinical strains of S. 
marcescens (32, 45). This supports our findings that the phages against this bacterium can be 
readily isolated from the wastewater in San Angelo; however, it does not appear that the 
relative number of these phages have been previously analyzed. Because our strain was 
isolated from a freshwater source, we first speculated that the phages that we detected in the 
water might have been introduced from the environment and not via human waste. If this was 
true, it was believed that it might have been beneficial to redo this portion of the experiment 
using a known clinical strain of the bacteria to ensure that the phages isolated have some sort 
of direct clinical relevance. However, a previous study showed that there did not seem to be a 
correlation between the source of the bacterial strain and its ability to be lysed by the 
bacteriophages for S. marcescens (32). In other words, the bacteriophages appeared to be 
specific for receptors common across all strains of S. marcescens.   
 The other species of tested bacteria to display evidence of bacteriophages was 
Staphylococcus aureus. Many strains of these bacteria, including MRSA, have previously 
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been shown to be present in wastewater systems albeit at low volumes (46). The lower 
quantity of phages isolated makes sense if there is an actual correlation between phages and 
the quantity of bacteria in the sewage as it has been shown that less staphylococci can be 
found in the raw sewage of a treatment plant as compared to the Enterobacteriaceae which 
include the genera Salmonella, Escherichia and Serratia (23). This could explain why there 
were no plaques until 0.9 mL of the phage mixture was used. The presence of lytic phages 
against pathogenic strains of Staph. aureus has been documented in farm wastewater; 
however, the relative numbers of these phages was not analyzed in previous studies (47). By 
reporting the number of phages isolated along with the concentration of our mixture our data 
might be useful to researchers who want to isolate phages against this bacterium. The phages 
isolated might have clinical use in controlling infections since the strain used in this 
experiment was isolated from a food source that had been implicated in causing 
staphylococcal food poisoning. With increasing numbers of reports describing the presence 
of MRSA in wastewater facilities, an additional analysis of the San Angelo Water 
Reclamation Facility using a strain of Staph. aureus that is resistant to Methicillin could 
prove useful in the fight against this difficult to treat pathogen.  
 One of the tested species that did not produce any phages was Staph. epidermidis. 
While Staph. epidermidis can be an extremely successful nosocomial infectious agent, it is 
usually only found on healthy human skin and mucosal linings throughout the body. As with 
Staph. aureus, this bacterium likely makes up only a small portion of the bacterial profile in 
sewage because of its sensitivity to the conditions that are inherent in this water source. 
However, bacteriophages have reportedly been isolated from other sources. Such sources 
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include the anterior nares and through mitomycin C induction of prophages (48,49). These 
have yielded only temperate phages which are not preferred for therapy. There has apparently 
only been one study that has successfully isolated Staph. epidermidis phages from 
wastewater. Melo et. al. isolated a broad-range strictly lytic phage called SEP-1 (50). Despite 
using a similar enrichment method that was used to isolate SEP-1, no phages were found in 
the present study. One difference between the enrichment methods used in our study and the 
study in the earlier publication was that their sewage-bacteria mixture was agitated at a low 
rpm during the 24-hour incubation period. This agitation could have allowed for more host-
phage interaction by limiting the number of bacteria that settled to the bottom of the broth 
and subsequently became unreachable to the phages. If the phages had been able to interact 
more freely with the bacteria, they may have been more readily capable of infection and 
thereby produce a detectable number of plaques. This could not be done in the present study 
because our lab did not have access to an incubation shaker so there was no way to 
continuously agitate the culture. In a future study it could be beneficial to try an enrichment 
experiment with Staph. epidermidis again and use the agitation method.  
 The other species tested in this study that did not produce any plaques, even after 
phage enrichment, was Strep. mutans. Very few phages have been isolated that can infect this 
bacterium and none of these have been from sewage (51). It seems that the present study is 
the first to evaluate the presence of phages for this bacterium in sewage as no other studies 
have been identified in the literature. Like those of Staph. epidermidis, most previously 
reported phages were isolated via mitomycin C induction of prophages which means they 
have very limited therapeutic use (51). The other phage that has previously been reported for 
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this bacterium originated from human saliva (39). As evidence of how rare this phage is, of 
the 81 saliva samples that were tested throughout the experiment, only one produced a 
bacteriophage (ɸAPM01) and in two other studies that tested saliva none were found. 
ɸAPM01 was shown to be serotype specific which means it has a very narrow host range and 
therefore may not be very useful in fighting dental caries. However, it did exhibit the ability 
to reduce the number of specific strains of Strep. mutans and their biofilms which, if 
combined with other phages or other antimicrobial agents, could be used to treat dental caries 
in their early stages.  
Because the phages are in such low quantity in the oral cavity, it makes sense that 
very few of them would be released into the wastewater. While there are many oral 
streptococci species found in raw sewage, only a small portion of these are likely to be Strep. 
mutans when their abundance in the human microbiome is taken into account (23). In a study 
aiming to identify the healthy human bacterial profile, the average relative abundance of 
streptococci species was established using 127 samples of saliva. These data illustrated that 
the most prevalent oral streptococci were Strep. parasanguis, Strep. salivarius, and Strep. 
infantis with Strep. mutans not making the top eleven (52). All of this information supports 
this study’s findings that there are no phages that can interact with these bacteria in the San 
Angelo wastewater system and future studies should take this information into consideration 
when attempting to isolate novel phages against it. However, as with Staph. epidermidis, the 
phage enrichment may need to be reevaluated using the methodology that agitates the 
mixture during the incubation period. 
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 There are multiple future directions that should be considered after analyzing the 
results of this project, the first being increasing the number of species of bacteria that are 
included in the search for phages. While important, the bacteria originally chosen for this 
project did not nearly encompass all of those that could be potentially treated with phage 
therapy. One example would be Pseudomonas aeruginosa. This is a gram-negative bacterium 
that is multi-drug resistant and is often an opportunistic pathogen most notably in burns and 
in cystic fibrosis patients. Since it can produce biofilms and it has acquired antimicrobial 
resistance, it is a great candidate for phage therapy. Already there have been isolates of 
phages against this bacterium isolated from wastewater, and one has demonstrated the ability 
to significantly reduce the biofilms produced by clinical isolates of this bacterium when 
combined with chlorine (53). There are many other bacteria that could theoretically be 
eliminated with bacteriophages, in combination with antimicrobials, and the San Angelo 
wastewater could potentially contain some that have yet to be discovered.  
 Another step forward with this project would be to isolate specific phages from the 
plaques produced in this study in order to determine their characteristics and to get an idea of 
their host range. Before a phage can be considered for use as a treatment, its interactions 
must be known. The first characteristic that should be identified is the type of life cycle it 
undergoes. The isolated phage must undergo a lytic lifecycle to be considered useful because 
this lessens the chance of transduction and the development of phage resistant bacteria. Next, 
the host range should be determined to know whether it will begin to impact the patient’s 
normal flora which nullifies one of the major advantages of using phages. Also, looking at 
these viruses under a transmission electron microscope would be advantageous in 
30 
understanding the phage. Knowing its morphological characteristics would help with 
determining its taxonomy, especially if combined with a genetic analysis. 
 Finally, more sources in San Angelo should be analyzed to look for the presence of 
other phages that could not be found in the raw sewage. Evaluating other phases in the water 
reclamation system could reveal different phages as there is a difference in the bacterial 
profile between raw sewage, activated sludge, and the effluent sewage. Furthermore, other 
locations in San Angelo, such as the Concho River, may reveal phages at different quantities 
and possibly with different characteristics.  
 In conclusion, although more work is needed to fully understand the full capabilities 
of these phages, they could be the answer to the increasing antimicrobial resistance. Even if 
they are not the final solution they could be a temporary stopgap to infection until another 
treatment is developed or new antibiotics are created. This call for phages as an alternative 
therapy cannot be answered without first knowing where they can be isolated. This study 
helps shed light on this issue by displaying the presence of bacteriophages against E. coli, S. 
typhimurium, S. marcescens and Staph. aureus in the wastewater of the San Angelo Water 
Reclamation Faculty. Equally important is knowing where not to look and the results of this 
study showed that this location was not a viable source for either Staph. epidermidis or Strep. 
mutans. Future studies can use this information to help determine where to search for novel 
phages.   
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